Kepler Capital Sticks to Their Buy Rating for Novartis AG (NOVN)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Evans is a 2-star analyst with an average return of 0.1% and a 55.72% success rate. Evans covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novartis AG, and Novo Nordisk.
Novartis AG has an analyst consensus of Moderate Buy, with a price target consensus of CHF102.20, a 6.39% upside from current levels. In a report released on July 4, Deutsche Bank also maintained a Buy rating on the stock with a CHF115.00 price target.
Based on Novartis AG's latest earnings release for the quarter ending March 30, the company reported a quarterly revenue of CHF13.62 billion and a net profit of CHF3.61 billion. In comparison, last year the company earned a revenue of CHF12.12 billion and had a net profit of CHF2.69 billion
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
25 minutes ago
- Business Insider
Goldman Sachs Weighs In on Tesla Stock Amid New SUV Reveal
Tesla (NASDAQ:TSLA) stock has been trending sideways lately, as investors weigh the company's longer-term delivery prospects against near-term uncertainties. However, a newly unveiled model in China may provide a modest boost to sentiment – though it's not the affordable compact many were expecting. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. After months of teasing a more affordable, compact vehicle, Tesla instead revealed a larger version of the Model Y, dubbed the Model YL. Shared via Weibo on Wednesday along with two images, the new variant is roughly seven inches longer and up to two inches taller than the standard Model Y, though still smaller than the Model X. According to China's Ministry of Industry and Information Technology, the Model YL is expected to launch in China this fall and will feature six seats. Goldman Sachs analyst Mark Delaney, ranked among the top 3% of Wall Street stock experts, views the Model YL as an 'incremental positive' that could help Tesla strengthen its foothold in the SUV segment – not just in China, but eventually in the U.S. and Europe as well. A central debate among investors has been how much the upcoming Tesla models in the back half of 2025 will drive meaningful growth. Delaney believes the YL is 'more differentiated' than many had expected, particularly given subdued expectations set during the Q1 earnings call. Rather than a cost-reduced, scaled-down Model Y, Tesla delivered something targeting the three-row SUV market – a surprising move that could open new demand channels. Delaney still expects a lower-cost Model Y or Model 3 variant to be introduced later this year, aligning with prior management hints. Tesla hasn't revealed the planned price for the Model YL, but according to media reports, the average selling price is expected to be around 400,000 RMB (approximately $56,000). For context, the Model Y starts at about 264,000 RMB (roughly $37,000) in China and around $45,000 in the U.S. The Model X, by comparison, starts at approximately $90,000 in the U. S. It's still unclear what features the Model YL will include at this price point – such as whether it will come with FSD, as Tesla initially offered with the refreshed Model Y in the U.S. – as well as its driving range or whether the price estimate is final. For comparison, Li Auto's L8 starts at 322,000 RMB and has averaged monthly sales of five to six thousand units over the past year. The L9, priced similarly at 410,000 RMB, sees comparable sales. In the U.S., entry prices for the Toyota Highlander and Ford Explorer are both around $40,000. Is Tesla stock worth buying right now? According to Delaney, not quite. The Goldman Sachs analyst maintains a Neutral rating on TSLA with a $285 price target – about 11% below current levels. (To watch Delaney's track record, click here) And he's not alone in his cautious stance. Of the 34 analysts who've weighed in over the past 3 months, the Street remains divided: 13 call it a Buy, 13 a Hold, and 8 say Sell. The average price target of $298.97 implies a 9% downside from current levels. (See TSLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Insider
5 hours ago
- Business Insider
Washington Federal (WAFD) Gets a Hold from D.A. Davidson
In a report released yesterday, Jeff Rulis from D.A. Davidson maintained a Hold rating on Washington Federal, with a price target of $33.00. The company's shares closed yesterday at $29.73. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Rulis is a 5-star analyst with an average return of 15.2% and a 71.20% success rate. Rulis covers the Financial sector, focusing on stocks such as Columbia Banking System, Enterprise Financial Services, and First Interstate Bancsystem. In addition to D.A. Davidson, Washington Federal also received a Hold from Piper Sandler's Matthew Clark in a report issued yesterday. However, on July 16, TR | OpenAI – 4o reiterated a Buy rating on Washington Federal (NASDAQ: WAFD). WAFD market cap is currently $2.38B and has a P/E ratio of 11.35.
Business Insider
5 hours ago
- Business Insider
Citizens JMP Sticks to Their Buy Rating for Procore Technologies (PCOR)
In a report released yesterday, Joe Goodwin from Citizens JMP reiterated a Buy rating on Procore Technologies, with a price target of $95.00. The company's shares closed yesterday at $74.13. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Goodwin is ranked #8359 out of 9841 analysts. Procore Technologies has an analyst consensus of Strong Buy, with a price target consensus of $79.42. PCOR market cap is currently $11.06B and has a P/E ratio of -86.35. Based on the recent corporate insider activity of 89 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PCOR in relation to earlier this year. Last month, William J.G. Griffith, a Director at PCOR sold 309,168.00 shares for a total of $20,018,353.62.
